Terms: = Skin cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
1736 results:
1. Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.
Sarin KY; Bradshaw M; O'Mara C; Shahryari J; Kincaid J; Kempers S; Tu JH; Dhawan S; DuBois J; Wilson D; Horwath P; de Souza MP; Powala C; Kochendoerfer GG; Plotkin SR; Webster GF; Le LQ
Sci Adv; 2024 May; 10(18):eadk4946. PubMed ID: 38691597
[TBL] [Abstract] [Full Text] [Related]
2.
Zhao A; Wang Y; Wang Z; Shao Q; Gong QI; Zhu H; Shen S; Liu HU; Chen X
Oncol Res; 2024; 32(5):983-998. PubMed ID: 38686044
[TBL] [Abstract] [Full Text] [Related]
3. The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cells.
Madej E; Lisek A; Brożyna AA; Cierniak A; Wronski N; Deptula M; Wardowska A; Wolnicka-Glubisz A
J Cancer Res Clin Oncol; 2024 Apr; 150(4):209. PubMed ID: 38656555
[TBL] [Abstract] [Full Text] [Related]
4. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
[TBL] [Abstract] [Full Text] [Related]
5. ACA-28, an erk MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic cancer Cells.
Takasaki T; Hamabe Y; Touchi K; Khandakar GI; Ueda T; Okada H; Sakai K; Nishio K; Tanabe G; Sugiura R
Oxid Med Cell Longev; 2024; 2024():7683793. PubMed ID: 38500550
[TBL] [Abstract] [Full Text] [Related]
6. Antibody targeting of surface P-selectin glycoprotein ligand 1 leads to lymphoma apoptosis and tumorigenesis inhibition.
Pereira JL; Ferreira F; Dos Santos NR
Hematol Oncol; 2024 Mar; 42(2):e3257. PubMed ID: 38415859
[TBL] [Abstract] [Full Text] [Related]
7. A novel NIR fluorescent probe inhibits melanoma progression through apoptosis and erk/DRP1-mediated mitochondrial fission.
He Q; Li C; Ou Y; Pan Y; Yang X; Wang J; Liao H; Xiong X; Liu L; Sun C
Bioorg Chem; 2024 Apr; 145():107218. PubMed ID: 38377820
[TBL] [Abstract] [Full Text] [Related]
8. CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance.
Kharouf N; Flanagan TW; Alamodi AA; Al Hmada Y; Hassan SY; Shalaby H; Santourlidis S; Hassan SL; Haikel Y; Megahed M; Brodell RT; Hassan M
Cells; 2024 Jan; 13(3):. PubMed ID: 38334632
[TBL] [Abstract] [Full Text] [Related]
9. Bufalin reprograms erythrocyte lifespan through p38 MAPK and Rac1 GTPase.
Alfhili MA; Alsughayyir J
Toxicon; 2024 Mar; 240():107636. PubMed ID: 38316294
[TBL] [Abstract] [Full Text] [Related]
10. Photoprotective Effects of Epigallocatechin Gallate on Ultraviolet-Induced Zebrafish and Human skin Fibroblasts Cells.
Zhang J; Xu Y; Ruan X; Zhang T; Zi M; Zhang Q
Mediators Inflamm; 2024; 2024():7887678. PubMed ID: 38304421
[TBL] [Abstract] [Full Text] [Related]
11. The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma.
Wu M; Hanly A; Gibson F; Fisher R; Rogers S; Park K; Zuger A; Kuang K; Kalin JH; Nocco S; Cole M; Xiao A; Agus F; Labadorf A; Beck S; Collard M; Cole PA; Alani RM
J Clin Invest; 2024 Feb; 134(6):. PubMed ID: 38300709
[TBL] [Abstract] [Full Text] [Related]
12. Sanguinarine Triggers Apoptosis in Cutaneous Squamous Cell Carcinoma Cells through Reactive Oxygen Species-Dependent c-Jun N-Terminal Kinase Signaling Pathway.
Patil K; Khan AQ; Ahmad F; Kuttikrishnan S; Anver R; Mateo JM; Ahmad A; Bhat AA; Buddenkotte J; Steinhoff M; Uddin S
Front Biosci (Landmark Ed); 2024 Jan; 29(1):40. PubMed ID: 38287817
[TBL] [Abstract] [Full Text] [Related]
13. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
[TBL] [Abstract] [Full Text] [Related]
14. Liprin-α1 contributes to oncogenic MAPK signaling by counteracting erk activity.
Pehkonen H; Filippou A; Väänänen J; Lindfors I; Vänttinen M; Ianevski P; Mäkelä A; Munne P; Klefström J; Toppila-Salmi S; Grénman R; Hagström J; Mäkitie AA; Karhemo PR; Monni O
Mol Oncol; 2024 Mar; 18(3):662-676. PubMed ID: 38264964
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides.
Bordeaux ZA; Reddy SV; Choi J; Braun G; McKeel J; Lu W; Yossef SM; Ma EZ; West CE; Kwatra SG; Kwatra MM
Sci Rep; 2024 Jan; 14(1):1955. PubMed ID: 38263212
[TBL] [Abstract] [Full Text] [Related]
16. Uncovering the Anti-Angiogenic Mechanisms of
Zhao B; Li Y; Wang B; Liu J; Yang Y; Quan Q; An Q; Liang R; Liu C; Yang C
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257275
[TBL] [Abstract] [Full Text] [Related]
17. Molecular Targeting of the BRAF Proto-Oncogene/Mitogen-Activated Protein Kinase (MAPK) Pathway across cancers.
Shan KS; Rehman TU; Ivanov S; Domingo G; Raez LE
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203795
[TBL] [Abstract] [Full Text] [Related]
18. [Clinical pathological and genetic mutation characteristics of conjunctival lymphoepithelial carcinoma].
Wang YC; Li J; Guo YT; Li J; Lin JY
Zhonghua Yan Ke Za Zhi; 2024 Jan; 60(1):64-71. PubMed ID: 38199770
[No Abstract] [Full Text] [Related]
19. Absent in melanoma 2 attenuates proliferation and migration and promotes apoptosis of human colorectal cancer cells by activating p38MAPK signaling pathway.
Zhang Z; Li X; Zhang Y; Zhu H; Qiao Z; Lu Y; Mi X; Cao H; Shen G; He S
Oncol Res; 2023; 32(2):353-360. PubMed ID: 38186575
[TBL] [Abstract] [Full Text] [Related]
20. The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor response.
Landolina N; Mariotti FR; Pelosi A; D'Oria V; Ingegnere T; Alicata C; Vacca P; Moretta L; Maggi E
Oncoimmunology; 2024; 13(1):2297504. PubMed ID: 38170019
[TBL] [Abstract] [Full Text] [Related]
[Next]
